Ads
related to: breast cancer cell lines- Patient Assistance Tool
Find Financial Support Options
For A NTRK+ Gene Fusion Cancer.
- Important Safety Info
See Full Safety And
Prescribing Information Here.
- Patient Assistance Tool
Search results
AstraZeneca-Daiichi's Enhertu follow-up Dato-DXd unable to prove overall survival benefit in phase 3
FierceBiotech· 2 days agoThe FDA accepted an application for Dato-Dxd as a treatment for non-squamous non-small cell lung ...
... for a CDK2 Inhibitor in Combination with an Approved CDK4/6 Inhibitor in HR+/HER2- Breast Cancer...
WROC Rochester· 7 days agoThe data, which mark the first promising clinical results for a CDK2 inhibitor in combination with an approved CDK4/6 inhibitor, will be presented at the 2024 American Society of Clinical Oncology ...
“Cell therapies change the definition of human”
Hardwood Paroxysm· 5 days agoThe researcher recently visited Barcelona to present his latest book, Cell harmony (debate) at the Institute of Bioengineering of Catalonia (IBEC), where...
Anti-Cancer Drug Pembrolizumab: Frequently Used Alone Or With Other Treatments
Forbes· 3 days agoPembrolizumab, sold as Keytruda by Merck & Co., was one of the first inhibitors to hit the market. A...
BostonGene Immune Profiling Platform Shows Promise in Predicting Cancer Immunotherapy Benefit
GenomeWeb News· 6 days agoThe firm and its scientific collaborators detailed the development, training, and initial validation of the platform this month in Cancer Cell, noting that ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 17 hours agoSixteen Researchers from Florida Cancer Specialists & Research Institute Share Cancer Care Discoveries at 2024 ASCO® Annual Meeting PR Newswire FORT MYERS ...
AstraZeneca and Daiichi Sankyo’s ADC improves survival in NSCLC trial
Clinical Trials Arena via Yahoo Finance· 3 days ago"AstraZeneca and Daiichi Sankyo’s ADC...
Hsa_circ_0007590/PTBP1 complex reprograms glucose metabolism by reducing the stability of...
Nature· 3 days agoRNA in situ hybridization (RNA-ISH) and quantitative reverse transcription PCR (qRT-PCR) were used to estimate hsa_circ_0007590 expression in PDAC clinical specimens and cell
Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why
Zacks· 6 days agoSales of Puma Biotechnology's (PBYI) sole marketed drug, Nerlynx, have been declining in recent quarters. Stiff competition in the target market is also a woe.
AstraZeneca (AZN) Falls on Failure to Meet NSCLC Study OS Goal
Zacks· 1 day agoAstraZeneca's (AZN) shares decline as it fails to achieve statistically significant overall survival data in a late-stage NSCLC study on Dato-DXd compared with docetaxel.